The US Food and Drug Administration (US FDA) has released a detailed report on six observations it reported following a recent inspection at Sun Pharmaceutical ... a Field Alert for Product ...
Regulatory troubles continue for Sun Pharma as the drug manufacturer’s Mumbai unit ... before taking any investment decisions. Advisory Alert: It has come to our attention that certain ...
On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the ...
Natco Pharma Ltd, a leading Indian pharmaceutical company, announced today that it has received a Warning Letter from the United States Food and Drug Administration (USFDA) regarding its ...
Sun Pharmaceutical ... drug portfolio in its core areas of dermatology and ophthalmology. This comes at a time when the company’s generic business continues to face pricing pressure. The company’s ...
Over 50 schools have received bomb threats, according to Times Now report. DCP New Delhi, Devesh Kumar Mahla said, "As a ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...
Mumbai-based pharmaceutical company, Sun Pharma Advanced Research Company Ltd. (SPARC), said it was abandoning its Phase 2 study on Vodobatinib for Parkinson's. The study was designed to evaluate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback